PetIQ Inc (PETQ)
30.98
0.00 (0.00%)
USD |
NASDAQ |
Oct 25, 16:00
PetIQ Gross Profit Margin (Quarterly): 26.84% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 26.84% |
March 31, 2024 | 24.17% |
December 31, 2023 | 20.00% |
September 30, 2023 | 26.21% |
June 30, 2023 | 23.49% |
March 31, 2023 | 21.43% |
December 31, 2022 | 21.34% |
September 30, 2022 | 24.21% |
June 30, 2022 | 24.59% |
March 31, 2022 | 20.91% |
December 31, 2021 | 18.76% |
September 30, 2021 | 19.98% |
June 30, 2021 | 22.00% |
March 31, 2021 | 18.79% |
December 31, 2020 | 17.41% |
September 30, 2020 | 19.91% |
June 30, 2020 | 15.80% |
Date | Value |
---|---|
March 31, 2020 | 17.22% |
December 31, 2019 | 13.26% |
September 30, 2019 | 14.67% |
June 30, 2019 | 15.82% |
March 31, 2019 | 16.66% |
December 31, 2018 | 15.23% |
September 30, 2018 | 18.41% |
June 30, 2018 | 15.38% |
March 31, 2018 | 13.80% |
December 31, 2017 | 20.27% |
September 30, 2017 | 20.67% |
June 30, 2017 | 18.30% |
March 31, 2017 | 18.20% |
December 31, 2016 | 17.04% |
September 30, 2016 | 14.78% |
June 30, 2016 | 14.62% |
March 31, 2016 | 18.69% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
13.26%
Minimum
Dec 2019
26.84%
Maximum
Jun 2024
20.86%
Average
20.91%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
Omeros Corp | -- |
BioCardia Inc | -- |
Revance Therapeutics Inc | 73.03% |
Zevra Therapeutics Inc | 19.69% |
Alector Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 5.52% |
Return on Assets | 1.51% |
Return on Invested Capital | 1.93% |
Profit Margin (Quarterly) | 4.66% |
Operating Margin (Quarterly) | 8.57% |
Return on Net Operating Assets | 1.69% |